Global Perceived Effect · patients with Chronic CGH
Chronic CGH: Cervical/Scapulothoracic Strengthening with Endurance… showed no clear difference in global Perceived Effect: VAS 0 to 100 ( compared with NO INTERVENTION (moderate certainty).
1 finding from 1 review
Adverse effects · patients with Chronic CGH
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients with mechanical neck disorders
1 finding from 1 review
Function: NDI 0 no disability to 50 maximum disability ( · patients with mechanical neck disorders
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · patients with mechanical neck disorders
1 finding from 1 review
Patient satisfaction Number of satisfied patients · patients with mechanical neck disorders
1 finding from 1 review
Global Perceived Effect · patients with mechanical neck disorders
1 finding from 1 review
Adverse effects · patients with mechanical neck disorders
1 finding from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · patients with Chronic CGH
Chronic CGH: Cervical/Scapulothoracic Strengthening with Endurance… showed no clear difference in pain Intensity: 6 weeks treatment VAS 0 no pain to 10 worst pain ( compared with manual Therapy (moderate certainty).
1 finding from 1 review
Function: NPNPQ 0% no disability to 100% maximum disability ( · patients with Chronic CGH
Chronic CGH: Cervical/Scapulothoracic Strengthening with Endurance… showed no clear difference in function: NPNPQ 0% no disability to 100% maximum disability ( compared with manual Therapy (moderate certainty).
1 finding from 1 review
Global Perceived Effect · patients with Chronic CGH
Chronic CGH: Cervical/Scapulothoracic Strengthening with Endurance… showed no clear difference in global Perceived Effect: VAS 0 to 100 ( compared with manual Therapy (moderate certainty).
1 finding from 1 review
Adverse effects · patients with Chronic CGH
1 finding from 1 review
Time to next pulmonary exacerbation · children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to next pulmonary exacerbation · adults and children with cystic fibrosis
1 finding from 1 review
Time to first pulmonary exacerbation · adults and children with cystic fibrosis
1 finding from 1 review
Pulmonary exacerbations · children with cystic fibrosis
1 finding from 1 review
Bronchopulmonary dysplasia/chronic lung disease · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in chronic lung disease/bronchopulmonary dysplasia (newborn/infant)** compared with placebo (outcomes (low certainty).
1 finding from 1 review
Death or bronchopulmonary dysplasia · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in death or bronchopulmonary dysplasia compared with surfactant administration via endotracheal tube (ETT) with the… (low certainty).
1 finding from 1 review
Pulmonary air leak · preterm infants with or at risk of respiratory distress syndrome
It is very uncertain whether surfactant administration via laryngeal mask airway (S‐LMA) changes pulmonary air leak, any (during first hospitalisation) Anytime to… compared with surfactant administration via endotracheal tube (ETT) with… (very low certainty).
1 finding from 1 review
Bronchopulmonary dysplasia · preterm infants with or at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found